J. Feldtrauer

发表

Release of endogenous glutamate from rat cortical slices in presence of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid

P. Waldmeier, P. Wicki, J. Feldtrauer, 1993, Naunyn-Schmiedeberg's Archives of Pharmacology.

Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters

M. Schmutz, P. Waldmeier, C. Stierlin, 1995, Neurology.

The measurement of the release of endogenous GABA from rat brain slices by liquid chromatography with electrochemical detection

P. Waldmeier, P. Baumann, P. Wicki, 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

The effects of amfonelic acid on 5-HT metabolism in rat brain

P. Waldmeier, A. Buchle, J. Feldtrauer, 2005, Journal of Neural Transmission.

Weak effects of local and systemic administration of the GABA uptake inhibitor, SK&F 89976, on extracellular GABA in the rat striatum

P. Waldmeier, J. Feldtrauer, K. Stöcklin, 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

Ca2+-dependent release of endogenous GABA from rat cortical slices from different pools by different stimulation conditions

P. Waldmeier, P. Baumann, P. Wicki, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811.

John J Lemasters, J. Lemasters, T. Qian, 2002, Molecular pharmacology.

METHYLHISTAMINE: EVIDENCE FOR SELECTIVE DEAMINATION BY MAO B IN THE RAT BRAIN IN VIVO

P. Waldmeier, L. Maître, J. Feldtrauer, 1977, Journal of neurochemistry.

On the role of O-methylation in the metabolism of S-adenosylmethionine in rat brain.

P. Waldmeier, J. Feldtrauer, 1987, Biochemical pharmacology.

Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A

K. Antonin, P. Bieck, P. Waldmeier, 2004, European Journal of Clinical Pharmacology.

Reversibility of the interaction of CGP 11305 A with MAO A in vivo.

P. Waldmeier, E. Paul, J. Feldtrauer, 1983, European journal of pharmacology.

Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro

P. Baumann, P. Wicki, J. Feldtrauer, 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

Inhibition and activation of enzymatic transfer of the methyl group from 5-methyltetrahydrofolate to tryptamine by catecholamine metabolites and analogues.

P. Waldmeier, L. Maître, J. Feldtrauer, 1975, Biochemical pharmacology.

Effects of the putative P-type calcium channel blocker, R,R-(−)-daurisoline on neurotransmitter release

P. Waldmeier, H. Bittiger, P. Wicki, 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.

GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors

P. Waldmeier, H. Bittiger, P. Baumann, 1994, British journal of pharmacology.

Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system.

P. Waldmeier, J. Feldtrauer, R. Kam, 1979, European journal of pharmacology.

CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure

P. Waldmeier, H. Bittiger, S. Bischoff, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Release of endogenous GABA from the substantia nigra is not controlled by GABA autoreceptors

P. Waldmeier, P. Baumann, P. Wicki, 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

Systemic administration of baclofen and the GABAB antagonist, CGP 35348, does not affect GABA, glutamate or aspartate in microdialysates of the striatum of conscious rats

P. Waldmeier, J. Feldtrauer, K. Stöcklin, 1992, Naunyn-Schmiedeberg's Archives of Pharmacology.

Effects of baclofen on striatal dopamine and serotonin metabolism

P. Waldmeier, J. Feldtrauer, B. Fehr, 1980, Brain Research Bulletin.